Moderna Seals Deal to Supply Israel with Coronavirus Vaccine
Many of the companies working to develop SARS-CoV-2 coronavirus vaccines aren't waiting around for clinical trials to be complete or government regulators to give their approval. They're ramping up manufacturing of their candidates even before it's clear whether or not they're effective at preventing COVID-19.
Taking a similar approach, at least one foreign government just signed a deal to buy a supply of one of those candidates before it becomes a licensed (and in-demand) pharmaceutical product: Israel's Health Ministry on Tuesday inked a deal with Moderna (NASDAQ: MRNA) for a quantity of its hopeful COVID-19 vaccine, dubbed mRNA-1273.
Contingent on the vaccine working, the U.S.-based biotech will deliver a significant quantity of mRNA-1273 once it becomes available, according to reports in Hebrew-language media. The particulars of the arrangement, such as deliverables and price, have not yet been made public, and Moderna hasn't made an official statement on the deal.
Source Fool.com
